Stay updated on NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.

Latest updates to the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new revision of the ClinicalTrials.gov page content. This likely reflects minor updates or corrections to the page materials rather than changes to the study details.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now reflects revision v3.6.2, replacing v3.6.0; this signals a software update with no apparent changes to the study details or layout.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study record now states 'No longer looking for participants', indicating recruitment is closed. New navigation items and sections such as How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment were added, while the old 'Intervention / Treatment' formatting and the revision tag were updated to v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now displays revision v3.5.5, indicating a small site update was applied. This change is administrative and does not alter study information or visible content.SummaryDifference0.0%

- Check63 days agoChange DetectedAdds a new Clin Cancer Res. 2026 publication citation for 'Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer' to the NADIM II Publications section and removes the earlier Clin Cancer Res. 2026 Mar 10 reference. This update reflects an upgrade to the study's listed publications, aligning with the most current literature cited in the trial record.SummaryDifference0.1%

- Check77 days agoChange DetectedNADIM II recruitment sites in Spain were updated, adding new locations and addresses while removing several previous sites to reflect a revised geographic footprint for participant enrollment.SummaryDifference4%

Stay in the know with updates to NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.